Navigation Links
Access Pharmaceuticals Presents at American Chemical Society Annual Fall Meeting in Boston, MA
Date:8/24/2010

op an oral formulation of a currently marketed, proprietary injectable drug, utilizing its proprietary Cobalamin Oral Drug Delivery Technology.  Although the name and the terms of the agreement have not been disclosed due to competitive reasons, management indicated that any successful formulation developed will be subject to a subsequent full-licensing agreement.

Cobalamin is Access' proprietary technology based upon the use of vitamin B12 for targeted delivery of drugs to disease sites and for oral drug delivery of drugs that otherwise have poor oral bioavailability. Access has focused its Cobalamin product development program on the oral delivery of insulin and human growth hormone, two peptides which currently can only be given by injection. Since presenting promising results at a major conference in mid-2008, Access has made substantial improvements to the formulation technology. A new Cobalamin-coated insulin-containing nanoparticle formulation delivered orally provided a pharmacological response (lowering of blood glucose levels in an animal model of diabetes) greater than 80% of that achieved by insulin delivered subcutaneously. This represents a substantial oral bioavailability, indicating that this formulation has potential for clinical development and ultimate commercialization. Adaptation of this technology has provided a Cobalamin human growth hormone formulation that has demonstrated good efficacy, represented by more than 25% improvement in weight gain, when given orally in an established animal model. Access continues to move both products towards clinical development.

About Access:Access Pharmaceuticals, Inc. is an emerging biopharmaceutical company that develops and commercializes proprietary products for the treatment and supportive care of cancer patients. Access' products include

SOURCE Access Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. US Oncology Helps Deliver Latest Cancer Therapies Through Local Community Access to Cutting Edge Research
2. Orchestrall Sponsors China Business Toolbox: Brings Focus to the How and When of China Market Access
3. DuPont Enhances its PROaccess℠ Business Strategy Through Acquisitions
4. Maximize Market Research to Improve Formulary Access Within Managed Markets Sector
5. Chinas first open-access journal Nano Research listed in Science Citation Index
6. Sudek of Tech Coast Angels Announces Networks Increased Commitment to Entrepreneurship and Innovation Through New Easy-Access Programs
7. Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe
8. Investor Relations Firm Access IR/PR and The Communications Strategy Group Announce Strategic Alliance
9. avVaa World Health Care Products Inc. Announces Access via Social Media Websites
10. Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan
11. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... (PRWEB) January 14, 2014 In recent ... motives and methods in product development and promotion has ... industry. This mistrust, fueled by concerns about the insidious ... by reports of spectacular fines to the world’s biggest ...
(Date:1/14/2014)... January 14, 2014 Global Record ... innovative information technology solutions for patients, physicians, the ... stakeholders, announced today the signing of a three-year ... and Drug Administration (FDA). This initiative is ...
(Date:1/14/2014)... and Cardiff, UK (PRWEB) January 13, 2014 ... development leader with more than 20 years in the ... optics and photonics . Hainsey will serve as the ... to have Dr. Hainsey join SPIE as our Technology ...
(Date:1/14/2014)... Rochester, NY (PRWEB) January 14, 2014 During ... is now known as “The Doctor’s Plague.” In this time ... their hands. This led, at times, to the death of ... staff today don’t know that they may be unwittingly transmitting ...
Breaking Biology Technology:The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... Corp.,(Nasdaq: GENZ ) announced today that it ... for the treatment of Hunter syndrome.,Elaprase is an ... Inc., and Genzyme is commercializing the product in ... with Shire. Genzyme intends,to launch Elaprase this quarter, ...
... Inc. (Nasdaq:,BIOD) today announced that Solomon Steiner, Chairman and CEO ... 2007 in San,Francisco, CA on October 11th at 11:00 AM ... live audio webcast of the,presentation in the investor relations section ... presentation will be available for,14 days. About Biodel Inc. ...
... new products, Skin Optimizer and Hyaluronic Acid Complex, promote ... skin and ... Formulas, recognized in,July by Nutrition Business Journal, selected BioCell Collagen ... the,effectiveness of two new Jarrow Formulas products -- Skin Optimizer ...
Cached Biology Technology:Genzyme Receives Approval to Market Elaprase(R) in Japan 2Genzyme Receives Approval to Market Elaprase(R) in Japan 3Genzyme Receives Approval to Market Elaprase(R) in Japan 4Biodel Inc. to Present at BIO InvestorForum 2007 Conference on October 11, 2007 2Jarrow Formulas Launches New Products Featuring BioCell Collagen II(R) 2
(Date:4/17/2014)... NY, April 17, 2014The development of stem cell therapies ... ability to characterize stem cell populations based on cell ... discovered a new marker that is highly expressed in ... cord blood, which they describe in an article in ... Mary Ann Liebert, Inc., publishers. The article is available ...
(Date:4/17/2014)... anthrax detection cartridge developed at Sandia National Laboratories and ... easier, faster and cheaper. , Bacillus anthracis ... in soils all over the world and can cause ... animals. The bacteria can survive in harsh conditions for ... may occur through skin contact, inhalation of spores or ...
(Date:4/17/2014)... produce hydrogen sulfide in order to properly multiply and ... the Center for Craniofacial Molecular Biology at the Herman ... Shi, principal investigator on the project, said the presence ... flow of calcium ions. The essential ions activate a ... the creation of new bone tissue, and keeps the ...
Breaking Biology News(10 mins):Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3
... Researchers have discovered how the protein Hap1, which is ... between circulating insulin in the blood and the neural ... of the neural pathway used by hormones to regulate ... targets for treating eating disorders and obesity. The ...
... The Walter and Eliza Hall Institute, using a mouse ... the formation of all breast tissue. This discovery lays ... develops. The identification of the breast stem cell is ... develops and how rogue cells evade current therapies. ...
... of an essential piece of the telomerase enzyme, an ... Understanding the physical shape of the protein has led ... immortalize cells ?and should help scientists design broadly effective ... structural information about the enzyme has hindered progress in ...
Cached Biology News:Hap1 protein links circulating insulin to brain circuits that regulate feeding behavior in mice 2Faults in newly discovered breast stem cells may lead to tumours 2Groovy protein essential for promoting cancer development 2Groovy protein essential for promoting cancer development 3Groovy protein essential for promoting cancer development 4
Amino-acids and Derivatives Rabbit Anti-conjugated L-isoleucine Polyclonal Antibody...
Anti-MMP-25 (Membrane-type MMP-6, Mt6MMP), hinge region; rabbit host...
Sheep polyclonal to Streptomycin ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule: Streptomycin conjugated to BSA....
Mouse monoclonal [SPM217] to Secretory Component Glycoprotein ( Abpromise for all tested applications)....
Biology Products: